1-3 of 3
Machiel H. Jansen
Close
Sort by
Journal Articles

Treatment of an HLH-mimic disease based on HAVCR2 variants with absent TIM-3 expression

Clinical Trials & Observations
Samantha A. M. Tromp, Marijn A. Gillissen, Sophie J. Bernelot Moens, Ester M. M. van Leeuwen, Machiel H. Jansen, Lianne Koens, Caroline E. Rutten, Taco W. Kuijpers
Journal: Blood Advances
Blood Adv (2022) 6 (15): 4501–4505.
https://doi.org/10.1182/bloodadvances.2022007450
Published: 2022
Includes: Supplemental data
Journal Articles

Activated neutrophils exert myeloid-derived suppressor cell activity damaging T cells beyond repair

Cathelijn E. M. Aarts, Ida H. Hiemstra, Eelke P. Béguin, Arjan J. Hoogendijk, Souhailla Bouchmal, Michel van Houdt, Anton T. J. Tool, Erik Mul, Machiel H. Jansen, Hans Janssen, Floris P. J. van Alphen, Jan-Paul de Boer, Charlotte L. Zuur, Alexander B. Meijer, Timo K. van den Berg, Taco W. Kuijpers
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3562–3574.
https://doi.org/10.1182/bloodadvances.2019031609
Published: 2019
Includes: Multimedia, Supplemental data
Journal Articles

Neutrophils acquire antigen-presenting cell features after phagocytosis of IgG-opsonized erythrocytes

Sanne M. Meinderts, Gabriella Baker, Stan van Wijk, Boukje M. Beuger, Judy Geissler, Machiel H. Jansen, Anno Saris, Anja ten Brinke, Taco W. Kuijpers, Timo K. van den Berg, Robin van Bruggen
Journal: Blood Advances
Blood Adv (2019) 3 (11): 1761–1773.
https://doi.org/10.1182/bloodadvances.2018028753
Published: 2019
Includes: Supplemental data